Penengo L - Search Results

1

Macrophage stimulating protein (MSP) evokes superoxide anion production by human macrophages of different origin.

Brunelleschi S, Penengo L, Lavagno L, Santoro C, Colangelo D, Viano I, Gaudino G. Brunelleschi S, et al. Among authors: penengo l. Br J Pharmacol. 2001 Nov;134(6):1285-95. doi: 10.1038/sj.bjp.0704356. Br J Pharmacol. 2001. PMID: 11704649 Free PMC article.

2

Receptor tyrosine kinases as target for anti-cancer therapy.

Brunelleschi S, Penengo L, Santoro MM, Gaudino G. Brunelleschi S, et al. Among authors: penengo l. Curr Pharm Des. 2002;8(22):1959-72. doi: 10.2174/1381612023393530. Curr Pharm Des. 2002. PMID: 12171522 Review.

3

c-Cbl is a critical modulator of the Ron tyrosine kinase receptor.

Penengo L, Rubin C, Yarden Y, Gaudino G. Penengo L, et al. Oncogene. 2003 Jun 12;22(24):3669-79. doi: 10.1038/sj.onc.1206585. Oncogene. 2003. PMID: 12802274

4

SV40 replication in human mesothelial cells induces HGF/Met receptor activation: a model for viral-related carcinogenesis of human malignant mesothelioma.

Cacciotti P, Libener R, Betta P, Martini F, Porta C, Procopio A, Strizzi L, Penengo L, Tognon M, Mutti L, Gaudino G. Cacciotti P, et al. Among authors: penengo l. Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):12032-7. doi: 10.1073/pnas.211026798. Epub 2001 Sep 25. Proc Natl Acad Sci U S A. 2001. PMID: 11572935 Free PMC article.

5

Geldanamycins trigger a novel Ron degradative pathway, hampering oncogenic signaling.

Germano S, Barberis D, Santoro MM, Penengo L, Citri A, Yarden Y, Gaudino G. Germano S, et al. Among authors: penengo l. J Biol Chem. 2006 Aug 4;281(31):21710-21719. doi: 10.1074/jbc.M602014200. Epub 2006 Jun 1. J Biol Chem. 2006. PMID: 16740632 Free article.

6

The Ron oncogenic activity induced by the MEN2B-like substitution overcomes the requirement for the multifunctional docking site.

Santoro MM, Penengo L, Orecchia S, Cilli M, Gaudino G. Santoro MM, et al. Among authors: penengo l. Oncogene. 2000 Oct 26;19(45):5208-11. doi: 10.1038/sj.onc.1203819. Oncogene. 2000. PMID: 11064459

7

Point mutations in the tyrosine kinase domain release the oncogenic and metastatic potential of the Ron receptor.

Santoro MM, Penengo L, Minetto M, Orecchia S, Cilli M, Gaudino G. Santoro MM, et al. Among authors: penengo l. Oncogene. 1998 Aug 13;17(6):741-9. doi: 10.1038/sj.onc.1201994. Oncogene. 1998. PMID: 9715276

8

RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX.

Pinato S, Scandiuzzi C, Arnaudo N, Citterio E, Gaudino G, Penengo L. Pinato S, et al. Among authors: penengo l. BMC Mol Biol. 2009 Jun 5;10:55. doi: 10.1186/1471-2199-10-55. BMC Mol Biol. 2009. PMID: 19500350 Free PMC article.

9

Nicotinamide phosphoribosyltransferase (NAMPT/PBEF/visfatin) is a tumoural cytokine released from melanoma.

Grolla AA, Torretta S, Gnemmi I, Amoruso A, Orsomando G, Gatti M, Caldarelli A, Lim D, Penengo L, Brunelleschi S, Genazzani AA, Travelli C. Grolla AA, et al. Among authors: penengo l. Pigment Cell Melanoma Res. 2015 Nov;28(6):718-29. doi: 10.1111/pcmr.12420. Pigment Cell Melanoma Res. 2015. PMID: 26358657

10

RNF168 promotes noncanonical K27 ubiquitination to signal DNA damage.

Gatti M, Pinato S, Maiolica A, Rocchio F, Prato MG, Aebersold R, Penengo L. Gatti M, et al. Among authors: penengo l. Cell Rep. 2015 Jan 13;10(2):226-38. doi: 10.1016/j.celrep.2014.12.021. Epub 2015 Jan 8. Cell Rep. 2015. PMID: 25578731 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page